WT1 immunoreactivity in uterine papillary serous carcinomas is different from ovarian serous carcinomas

American Journal of Clinical Pathology

Volumn 117, Issue 4, 2002, Pages 541-545

  Goldstein, Neal S ^a   Uzieblo, Alison ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

Immunohistochemistry; Ovary; Papillary; Serous; Uterus; WT1

Indexed keywords

ANTIBODY LABELING; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; FEMALE; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; OVARY CARCINOMA; OVARY METASTASIS; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; UTERUS CARCINOMA; WT1 GENE;

CELL NUCLEUS; CYSTADENOCARCINOMA; CYSTADENOCARCINOMA, PAPILLARY; CYTOPLASM; ENDOTHELIUM; FEMALE; GENE EXPRESSION; HUMANS; NEOPLASM METASTASIS; OVARIAN NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53; UTERINE NEOPLASMS; WT1 PROTEINS;

EID: 0036329040     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/K84K-005F-TCB8-FV4B     Document Type: Article

References (17)

1. Neoadjuvant chemotherapy in uterine papillary serous carcinoma
2. Expression of the Wilms' tumor gene WT1 in the murine urogenital system
3. HBME-1, MOC-31, WT1 and calretinin: An assessment of recently described markers for mesothelioma and adenocarcinoma
4. Role of immunohistochemistry in distinguishing epithelial peritoneal mesotheliomas from peritoneal and ovarian serous carcinomas
5. Genetic alterations of the WT1 gene in papillary serous carcinoma of the peritoneum
6. Immunohistochemical detection of the Wilms' tumor gene (WT1) in epithelial ovarian tumors
7. WT1 is an integral component of an antibody panel to distinguish pancreaticobiliary and some ovarian epithelial neoplasms
8. Value of thyroid transcription factor-1, E- cadherin, BG8, WT1, and CD44S immunostaining in distinguishing epithelial pleural mesothelioma from pulmonary and nonpulmonary adenocarcinoma
9. The frequency of p53, Kras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma: Evidence of distinct molecular genetic pathways
10. Hysteroscopic and immunohistochemical findings in type I and type II endometrial carcinomas
11. Endometrial intraepithelial carcinoma with associated peritoneal carcinomatosis
12. p53 immunostaining as a significant adjunct diagnostic method for uterine surface carcinoma: Precursor of uterine papillary serous carcinoma
13. Genomic alterations in fallopian tube carcinoma: Comparison to serous uterine and ovarian carcinomas reveals similarity suggesting likeness in molecular pathogenesis
14. Comparative analysis of histologic homologues of endometrial and ovarian carcinoma
15. Alternative splicing and genomic structure of the Wilms tumor gene WT1
16. Epitopes of carcinoembryonic antigen by monoclonal antibodies prepared from mice immunized with purified carcinoembryonic antigen or HCT-8R cells
17. Functional properties of WT1